KESTRA MEDICAL TECHNOLOGIES, LTD.: president and chief executive officer Webster Brian Daniel sold 15,000 shares

What happened

• Webster Brian Daniel, president and chief executive officer, sold a total of 15,000 shares in two open-market transactions on Oct 20, 2026: 13,316 shares at a weighted average price of $29.52 for $393,051, and 1,684 shares at a weighted average price of $29.89 for $50,338.

Key details

• Transaction date: Oct 20, 2026.
• Prices reported: weighted average $29.52 (range $28.8568 to $29.8475) and weighted average $29.89 (range $29.8600 to $29.9200). The filer will provide breakdown of shares at each price upon request (see footnotes).
• Total proceeds reported: $443,389.
• Shares owned after the transaction: not reported in the supplied filing.
• Footnote: the sales were made pursuant to a Rule 10b5-1 trading plan adopted Jul 21, 2026.
• Filing date: Oct 22, 2026.

Why it may matter

• These were open-market sales executed under a Rule 10b5-1 trading plan.
• The filing does not show why the insider traded or why the company acted.